⚠️Prescription Required

Switglim-MV 2/0.3 mg Tablet 10’s is a combination of three antidiabetic drugs: Glimepiride, Metformin and Voglibose. Glimepiride, which is a ‘sulfonylurea’, acts by increasing the amount of insulin released by the pancreas. Metformin, which is a ‘biguanide’, acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body’s response to insulin. Voglibose, which is an ‘alpha-glucosidase inhibitor’, prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine. In a nutshell, the three medicines together prevent the blood glucose levels from rising to very high levels, thus keeping your diabetes under control.

Switglim-MV 2/0.3 mg Tablet 10’s should be taken with food to avoid an upset stomach. Based on your medical condition, your doctor will decide for how long you need to take Switglim-MV 2/0.3 mg Tablet 10’s. Switglim-MV 2/0.3 mg Tablet 10’s may cause certain common side effects such as hypoglycaemia (low blood glucose levels), taste change, nausea, diarrhoea, stomach pain, headache, upper respiratory symptoms. Most of these side effects do not require medical attention and will resolve gradually over time. However, if you experience these side effects persistently, consult your doctor.

Caution:
Continue taking Switglim-MV 2/0.3 mg Tablet 10’s for as long as your doctor has advised. If you stop taking Switglim-MV 2/0.3 mg Tablet 10’s abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Switglim-MV 2/0.3 mg Tablet 10’s should not be taken if you have type 1 diabetes mellitus, severe kidney or liver disease. Please inform your doctor if you have any type of heart disease, are planning to get pregnant or are breastfeeding.

Uses of Switglim-MV 2/0.3 mg Tablet 10’s
Type 2 diabetes mellitus

Medicinal Benefits
Switglim-MV 2/0.3 mg Tablet 10’s contains Glimepiride, Metformin and Voglibose. Glimepiride, which is a ‘sulfonylurea’, acts by increasing the amount of insulin released by the pancreas. Metformin, which is a ‘biguanide’, acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body’s response to insulin. Voglibose, which is an ‘alpha-glucosidase inhibitor’ prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine.

Switglim-MV 2/0.3 mg Tablet 10’s prevents the blood glucose levels from rising to very high levels thus keeping your diabetes under control. Switglim-MV 2/0.3 mg Tablet 10’s also helps to prevent serious complications of diabetes such as kidney damage (Diabetic Nephropathy), blindness (Diabetic Retinopathy), loss of sensation in your hands and feet (Diabetic Neuropathy), Switglim-MV 2/0.3 mg Tablet 10’s also helps to reduce your chance of having a heart attack or stroke. Being a combination of three drugs, Switglim-MV 2/0.3 mg Tablet 10’s reduces the need to take multiple pills and hence makes it easier to remember to take the drugs.

Directions for Use
Swallow it as a whole with a glass of water. Do not chew or crush it.

Storage
Store in a cool and dry place away from sunlight

Side Effects of Switglim-MV 2/0.3 mg Tablet 10’s

• Hypoglycaemia (low blood glucose level)
• Taste change
• Nausea
• Diarrhoea
• Stomach pain
• Flatulence
• Headache
• Upper respiratory symptoms

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.